{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T06:40:37Z","timestamp":1792737637981,"version":"4.5.0"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T00:00:00Z","timestamp":1747612800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T00:00:00Z","timestamp":1747612800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"crossref","award":["RS-2024-00399237"],"award-info":[{"award-number":["RS-2024-00399237"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"crossref","award":["2021R1F1A1049347"],"award-info":[{"award-number":["2021R1F1A1049347"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100024838","name":"Samsung Medical Center, Sungkyunkwan University","doi-asserted-by":"crossref","award":["SMO1220511"],"award-info":[{"award-number":["SMO1220511"]}],"id":[{"id":"10.13039\/501100024838","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002647","name":"Sungkyunkwan University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002647","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1007\/s12035-025-04932-3","type":"journal-article","created":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T05:19:50Z","timestamp":1747631990000},"page":"12280-12295","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Serum sEV miRNAs as Biomarkers in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease"],"prefix":"10.1007","volume":"62","author":[{"given":"Hark Kyun","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyunjin","family":"Ju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeon Hak","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun-Seon","family":"Ju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongeun","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeji","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Gyu","family":"Jo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju-Hong","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,19]]},"reference":[{"issue":"9","key":"4932_CR1","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/S1474-4422(21)00218-0","volume":"20","author":"R Marignier","year":"2021","unstructured":"Marignier R, Hacohen Y, Cobo-Calvo A, Probstel AK, Aktas O, Alexopoulos H et al (2021) Myelin-oligodendrocyte glycoprotein antibody-associated disease. Lancet Neurol 20(9):762\u2013772","journal-title":"Lancet Neurol"},{"issue":"5","key":"4932_CR2","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1093\/brain\/awaa102","volume":"143","author":"Y Takai","year":"2020","unstructured":"Takai Y, Misu T, Kaneko K, Chihara N, Narikawa K, Tsuchida S et al (2020) Myelin oligodendrocyte glycoprotein antibody-associated disease: an immunopathological study. Brain 143(5):1431\u20131446","journal-title":"Brain"},{"issue":"10422","key":"4932_CR3","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S0140-6736(23)01473-3","volume":"403","author":"D Jakimovski","year":"2024","unstructured":"Jakimovski D, Bittner S, Zivadinov R, Morrow SA, Benedict RH, Zipp F et al (2024) Multiple sclerosis. Lancet 403(10422):183\u2013202","journal-title":"Lancet"},{"issue":"3","key":"4932_CR4","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/S1474-4422(22)00431-8","volume":"22","author":"B Banwell","year":"2023","unstructured":"Banwell B, Bennett JL, Marignier R, Kim HJ, Brilot F, Flanagan EP et al (2023) Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria. The Lancet Neurology 22(3):268\u2013282","journal-title":"The Lancet Neurology"},{"key":"4932_CR5","doi-asserted-by":"crossref","unstructured":"Lipps P, Ayroza Galvao Ribeiro Gomes AB, Kulsvehagen L, Mutke MA, Kuhle J, Papadopoulou A, et al (2023) Ongoing challenges in the diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease. JAMA Neurol 80(12):1377\u20139.","DOI":"10.1001\/jamaneurol.2023.3956"},{"issue":"8","key":"4932_CR6","doi-asserted-by":"publisher","first-page":"e2250228","DOI":"10.1002\/eji.202250228","volume":"53","author":"AJ Gill","year":"2023","unstructured":"Gill AJ, Schorr EM, Gadani SP, Calabresi PA (2023) Emerging imaging and liquid biomarkers in multiple sclerosis. Eur J Immunol 53(8):e2250228","journal-title":"Eur J Immunol"},{"key":"4932_CR7","doi-asserted-by":"publisher","first-page":"1415535","DOI":"10.3389\/fneur.2024.1415535","volume":"15","author":"RE Rodin","year":"2024","unstructured":"Rodin RE, Chitnis T (2024) Soluble biomarkers for neuromyelitis optica spectrum disorders: a mini review. Front Neurol 15:1415535","journal-title":"Front Neurol"},{"issue":"1","key":"4932_CR8","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.cell.2018.03.006","volume":"173","author":"DP Bartel","year":"2018","unstructured":"Bartel DP (2018) Metazoan MicroRNAs. Cell 173(1):20\u201351","journal-title":"Cell"},{"key":"4932_CR9","doi-asserted-by":"crossref","unstructured":"Xu D, Di K, Fan B, Wu J, Gu X, Sun Y, et al (2022) MicroRNAs in extracellular vesicles: sorting mechanisms, diagnostic value, isolation, and detection technology. Frontiers in Bioengineering and Biotechnology 10","DOI":"10.3389\/fbioe.2022.948959"},{"key":"4932_CR10","doi-asserted-by":"crossref","unstructured":"Cheng L, Sharples RA, Scicluna BJ, Hill AF (2014) Exosomes provide a protective and enriched source of miRNA for biomarker profiling compared to intracellular and cell-free blood. J Extracell Vesicles 3","DOI":"10.3402\/jev.v3.23743"},{"issue":"1652","key":"4932_CR11","doi-asserted-by":"publisher","first-page":"20130516","DOI":"10.1098\/rstb.2013.0516","volume":"369","author":"DM Pegtel","year":"2014","unstructured":"Pegtel DM, Peferoen L, Amor S (2014) Extracellular vesicles as modulators of cell-to-cell communication in the healthy and diseased brain. Philos Transac Royal Soc B: Biol Sci 369(1652):20130516","journal-title":"Philos Transac Royal Soc B: Biol Sci"},{"key":"4932_CR12","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/1742-2094-11-68","volume":"11","author":"A Gupta","year":"2014","unstructured":"Gupta A, Pulliam L (2014) Exosomes as mediators of neuroinflammation. J Neuroinflammation 11:68","journal-title":"J Neuroinflammation"},{"issue":"1","key":"4932_CR13","doi-asserted-by":"publisher","first-page":"14293","DOI":"10.1038\/s41598-017-14301-3","volume":"7","author":"S Ebrahimkhani","year":"2017","unstructured":"Ebrahimkhani S, Vafaee F, Young PE, Hur SSJ, Hawke S, Devenney E et al (2017) Exosomal microRNA signatures in multiple sclerosis reflect disease status. Sci Rep 7(1):14293","journal-title":"Sci Rep"},{"issue":"2","key":"4932_CR14","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1007\/s12035-019-01792-6","volume":"57","author":"S Ebrahimkhani","year":"2020","unstructured":"Ebrahimkhani S, Beadnall HN, Wang C, Suter CM, Barnett MH, Buckland ME et al (2020) Serum exosome microRNAs predict multiple sclerosis disease activity after Fingolimod treatment. Mol Neurobiol 57(2):1245\u20131258","journal-title":"Mol Neurobiol"},{"issue":"6","key":"4932_CR15","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1002\/ana.23880","volume":"73","author":"R Gandhi","year":"2013","unstructured":"Gandhi R, Healy B, Gholipour T, Egorova S, Musallam A, Hussain MS et al (2013) Circulating microRNAs as biomarkers for disease staging in multiple sclerosis. Ann Neurol 73(6):729\u2013740","journal-title":"Ann Neurol"},{"issue":"3","key":"4932_CR16","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.3390\/ijms23031664","volume":"23","author":"N Cuomo-Haymour","year":"2022","unstructured":"Cuomo-Haymour N, Bergamini G, Russo G, Kulic L, Knuesel I, Martin R et al (2022) Differential expression of serum extracellular vesicle miRNAs in multiple sclerosis: disease-stage specificity and relevance to pathophysiology. Int J Mol Sci 23(3):1664","journal-title":"Int J Mol Sci"},{"key":"4932_CR17","doi-asserted-by":"crossref","unstructured":"Keller A, Leidinger P, Meese E, Haas J, Backes C, Rasche L, et al (2015) Next-generation sequencing identifies altered whole blood microRNAs in neuromyelitis optica spectrum disorder which may permit discrimination from multiple sclerosis. Journal of Neuroinflammation 12(1).","DOI":"10.1186\/s12974-015-0418-1"},{"key":"4932_CR18","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.3389\/fimmu.2020.01064","volume":"11","author":"C Chen","year":"2020","unstructured":"Chen C, Wu Y, Li M, Cui C, Zhao Y, Sun X et al (2020) Different exosomal microRNA profile in aquaporin-4 antibody positive neuromyelitis optica spectrum disorders. Front Immunol 11:1064","journal-title":"Front Immunol"},{"key":"4932_CR19","doi-asserted-by":"crossref","unstructured":"Wang Y, Xie C, Song Y, Xiang W, Peng J, Han L, et al. miR-20a suppresses Treg differentiation by targeting Map3k9 in experimental autoimmune encephalomyelitis. Journal of Translational Medicine. 2021;19(1).","DOI":"10.1186\/s12967-021-02893-4"},{"issue":"2","key":"4932_CR20","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","volume":"17","author":"AJ Thompson","year":"2018","unstructured":"Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G et al (2018) Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 17(2):162\u2013173","journal-title":"Lancet Neurol"},{"issue":"2","key":"4932_CR21","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","volume":"85","author":"DM Wingerchuk","year":"2015","unstructured":"Wingerchuk DM, Banwell B, Bennett JL, Cabre P, Carroll W, Chitnis T et al (2015) International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 85(2):177\u2013189","journal-title":"Neurology"},{"issue":"3","key":"4932_CR22","doi-asserted-by":"publisher","first-page":"e89","DOI":"10.1212\/NXI.0000000000000089","volume":"2","author":"P Waters","year":"2015","unstructured":"Waters P, Woodhall M, O\u2019Connor KC, Reindl M, Lang B, Sato DK et al (2015) MOG cell-based assay detects non-MS patients with inflammatory neurologic disease. Neurol Neuroimmunol Neuroinflamm 2(3):e89","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"1","key":"4932_CR23","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3343\/alm.2024.44.1.56","volume":"44","author":"JM Seok","year":"2024","unstructured":"Seok JM, Waters P, Jeon MY, Lee HL, Baek SH, Park JS et al (2024) Clinical usefulness of a cell-based assay for detecting myelin oligodendrocyte glycoprotein antibodies in central nervous system inflammatory disorders. Ann Lab Med 44(1):56\u201363","journal-title":"Ann Lab Med"},{"issue":"5","key":"4932_CR24","doi-asserted-by":"publisher","first-page":"331","DOI":"10.3343\/alm.2012.32.5.331","volume":"32","author":"ES Kang","year":"2012","unstructured":"Kang ES, Min JH, Lee KH, Kim BJ (2012) Clinical usefulness of cell-based indirect immunofluorescence assay for the detection of aquaporin-4 antibodies in neuromyelitis optica spectrum disorder. Ann Lab Med 32(5):331\u2013338","journal-title":"Ann Lab Med"},{"issue":"1","key":"4932_CR25","doi-asserted-by":"publisher","first-page":"e12179","DOI":"10.1002\/jev2.12179","volume":"11","author":"HK Kim","year":"2022","unstructured":"Kim HK, Cho J, Kim E, Kim J, Yang JS, Kim KC et al (2022) Engineered small extracellular vesicles displaying ACE2 variants on the surface protect against SARS-CoV-2 infection. J Extracell Vesicles 11(1):e12179","journal-title":"J Extracell Vesicles"},{"issue":"11","key":"4932_CR26","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1093\/bioinformatics\/bts188","volume":"28","author":"D Waggott","year":"2012","unstructured":"Waggott D, Chu K, Yin S, Wouters BG, Liu FF, Boutros PC (2012) NanoStringNorm: an extensible R package for the pre-processing of NanoString mRNA and miRNA data. Bioinformatics 28(11):1546\u20131548","journal-title":"Bioinformatics"},{"issue":"17","key":"4932_CR27","doi-asserted-by":"publisher","first-page":"e133","DOI":"10.1093\/nar\/gku631","volume":"42","author":"Y Ru","year":"2014","unstructured":"Ru Y, Kechris KJ, Tabakoff B, Hoffman P, Radcliffe RA, Bowler R et al (2014) The multiMiR R package and database: integration of microRNA-target interactions along with their disease and drug associations. Nucleic Acids Res 42(17):e133","journal-title":"Nucleic Acids Res"},{"issue":"W1","key":"4932_CR28","doi-asserted-by":"publisher","first-page":"W216","DOI":"10.1093\/nar\/gkac194","volume":"50","author":"BT Sherman","year":"2022","unstructured":"Sherman BT, Hao M, Qiu J, Jiao X, Baseler MW, Lane HC et al (2022) DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update). Nucleic Acids Res 50(W1):W216\u2013W221","journal-title":"Nucleic Acids Res"},{"key":"4932_CR29","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/1471-2105-12-77","volume":"12","author":"X Robin","year":"2011","unstructured":"Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez JC et al (2011) pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics 12:77","journal-title":"BMC Bioinformatics"},{"issue":"1","key":"4932_CR30","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s12974-023-02811-z","volume":"20","author":"A Gonzalez-Martinez","year":"2023","unstructured":"Gonzalez-Martinez A, Patel R, Healy BC, Lokhande H, Paul A, Saxena S et al (2023) miRNA 548a\u20133p as biomarker of NEDA-3 at 2 years in multiple sclerosis patients treated with fingolimod. J Neuroinflammation 20(1):131","journal-title":"J Neuroinflammation"},{"key":"4932_CR31","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.12659\/MSM.904642","volume":"23","author":"J Chen","year":"2017","unstructured":"Chen J, Zhu J, Wang Z, Yao X, Wu X, Liu F et al (2017) MicroRNAs correlate with multiple sclerosis and neuromyelitis optica spectrum disorder in a chinese population. Med Sci Monit 23:2565\u20132583","journal-title":"Med Sci Monit"},{"issue":"4","key":"4932_CR32","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1177\/0961203314522335","volume":"23","author":"R Martinez-Ramos","year":"2014","unstructured":"Martinez-Ramos R, Garcia-Lozano JR, Lucena JM, Castillo-Palma MJ, Garcia-Hernandez F, Rodriguez MC et al (2014) Differential expression pattern of microRNAs in CD4+ and CD19+ cells from asymptomatic patients with systemic lupus erythematosus. Lupus 23(4):353\u2013359","journal-title":"Lupus"},{"key":"4932_CR33","doi-asserted-by":"crossref","unstructured":"Song G, Li L, Yang Y (2020) MicroRNA\u2011329\u20113p alleviates high glucose\u2011induced endothelial cell injury via inhibition of the TLR4\/TRAF6\/NF\u2011κB signaling pathway. Experimental and Therapeutic Medicine 21(1):1-.","DOI":"10.3892\/etm.2020.9461"},{"key":"4932_CR34","doi-asserted-by":"publisher","first-page":"111352","DOI":"10.1016\/j.mad.2020.111352","volume":"191","author":"AD Henriques","year":"2020","unstructured":"Henriques AD, Machado-Silva W, Leite RE, Suemoto CK, Leite KR, Srougi M et al (2020) Genome-wide profiling and predicted significance of post-mortem brain microRNA in Alzheimer\u2019s disease. Mech Ageing Dev 191:111352","journal-title":"Mech Ageing Dev"},{"key":"4932_CR35","doi-asserted-by":"publisher","first-page":"136892","DOI":"10.1016\/j.neulet.2022.136892","volume":"790","author":"Y Wang","year":"2022","unstructured":"Wang Y, Lv S, Zhou X, Niu X, Chen L, Yang Z et al (2022) Identification of hsa-miR-365b-5p\u2019s role in Alzheimer\u2019s disease: a combined analysis of miRNA and mRNA microarrays. Neurosci Lett 790:136892","journal-title":"Neurosci Lett"},{"issue":"1","key":"4932_CR36","doi-asserted-by":"publisher","first-page":"6645","DOI":"10.1038\/s41598-024-57166-z","volume":"14","author":"F Dakroub","year":"2024","unstructured":"Dakroub F, Kobeissy F, Mondello S, Yang Z, Xu H, Sura L et al (2024) MicroRNAs as biomarkers of brain injury in neonatal encephalopathy: an observational cohort study. Sci Rep 14(1):6645","journal-title":"Sci Rep"},{"issue":"3","key":"4932_CR37","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1007\/s12035-019-01797-1","volume":"57","author":"DLG Gitai","year":"2020","unstructured":"Gitai DLG, Dos Santos YDR, Upadhya R, Kodali M, Madhu LN, Shetty AK (2020) Extracellular vesicles in the forebrain display reduced miR-346 and miR-331-3p in a rat model of chronic temporal lobe epilepsy. Mol Neurobiol 57(3):1674\u20131687","journal-title":"Mol Neurobiol"},{"key":"4932_CR38","doi-asserted-by":"publisher","first-page":"1209749","DOI":"10.3389\/fneur.2023.1209749","volume":"14","author":"Y Takai","year":"2023","unstructured":"Takai Y, Misu T, Fujihara K, Aoki M (2023) Pathology of myelin oligodendrocyte glycoprotein antibody-associated disease: a comparison with multiple sclerosis and aquaporin 4 antibody-positive neuromyelitis optica spectrum disorders. Front Neurol 14:1209749","journal-title":"Front Neurol"},{"key":"4932_CR39","doi-asserted-by":"publisher","first-page":"1137998","DOI":"10.3389\/fneur.2023.1137998","volume":"14","author":"O Corbali","year":"2023","unstructured":"Corbali O, Chitnis T (2023) Pathophysiology of myelin oligodendrocyte glycoprotein antibody disease. Front Neurol 14:1137998","journal-title":"Front Neurol"},{"issue":"8","key":"4932_CR40","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1007\/s11064-018-2567-y","volume":"43","author":"R Shi","year":"2018","unstructured":"Shi R, Zhang S, Cheng G, Yang X, Zhao N, Chen C (2018) Ginsenoside Rg1 and Acori Graminei rhizoma attenuates neuron cell apoptosis by promoting the expression of miR-873-5p in Alzheimer\u2019s disease. Neurochem Res 43(8):1529\u20131538","journal-title":"Neurochem Res"},{"issue":"9","key":"4932_CR41","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1097\/00001756-200107030-00016","volume":"12","author":"Y Liu","year":"2001","unstructured":"Liu Y, Zhu B, Luo L, Li P, Paty DW, Cynader MS (2001) Heme oxygenase-1 plays an important protective role in experimental autoimmune encephalomyelitis. NeuroReport 12(9):1841\u20131845","journal-title":"NeuroReport"},{"key":"4932_CR42","doi-asserted-by":"publisher","first-page":"743701","DOI":"10.3389\/fonc.2021.743701","volume":"11","author":"Y Zou","year":"2021","unstructured":"Zou Y, Zhong C, Hu Z, Duan S (2021) MiR-873-5p: a potential molecular marker for cancer diagnosis and prognosis. Front Oncol 11:743701","journal-title":"Front Oncol"},{"issue":"1","key":"4932_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/sigtrans.2017.23","volume":"2","author":"T Liu","year":"2017","unstructured":"Liu T, Zhang L, Joo D, Sun S-C (2017) NF-\u03baB signaling in inflammation. Signal Transduct Target Ther 2(1):1\u20139","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"4932_CR44","doi-asserted-by":"publisher","first-page":"e1038","DOI":"10.1212\/NXI.0000000000001038","volume":"9","author":"F Shimizu","year":"2021","unstructured":"Shimizu F, Ogawa R, Mizukami Y, Watanabe K, Hara K, Kadono C et al (2021) GRP78 antibodies are associated with blood-brain barrier breakdown in anti\u2013myelin oligodendrocyte glycoprotein antibody\u2013associated disorder. Neurology Neuroimmunology & Neuroinflammation 9(1):e1038","journal-title":"Neurology Neuroimmunology & Neuroinflammation"},{"issue":"8","key":"4932_CR45","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.2174\/1871520619666190206165215","volume":"19","author":"S Akgun","year":"2019","unstructured":"Akgun S, Kucuksayan H, Ozes ON, Can O, Alikanoglu AS, Yildiz M et al (2019) NF-\u03baB-induced upregulation of miR-548as-3p increases invasion of NSCLC by targeting PTEN. Anti-Cancer Agents in Medicinal Chemistry-Anti-Cancer Agents 19(8):1058\u201368","journal-title":"Anti-Cancer Agents in Medicinal Chemistry-Anti-Cancer Agents"},{"key":"4932_CR46","doi-asserted-by":"publisher","first-page":"890420","DOI":"10.3389\/fpubh.2022.890420","volume":"10","author":"KE Miller","year":"2022","unstructured":"Miller KE, MacDonald JP, Sullivan L, Venkata LPR, Shi J, Yeates KO et al (2022) Salivary miRNA expression in children with persistent post-concussive symptoms. Front Public Health 10:890420","journal-title":"Front Public Health"},{"issue":"8","key":"4932_CR47","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1177\/0960327121991899","volume":"40","author":"Y Xiao","year":"2021","unstructured":"Xiao Y, Zheng S, Duan N, Li X, Wen J (2021) MicroRNA-26b-5p alleviates cerebral ischemia-reperfusion injury in rats via inhibiting the N-myc\/PTEN axis by downregulating KLF10 expression. Hum Exp Toxicol 40(8):1250\u20131262","journal-title":"Hum Exp Toxicol"},{"issue":"1","key":"4932_CR48","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s12951-024-02336-4","volume":"22","author":"Y Qian","year":"2024","unstructured":"Qian Y, Chu G, Zhang L, Wu Z, Wang Q, Guo JJ et al (2024) M2 macrophage-derived exosomal miR-26b-5p regulates macrophage polarization and chondrocyte hypertrophy by targeting TLR3 and COL10A1 to alleviate osteoarthritis. J Nanobiotechnol 22(1):72","journal-title":"J Nanobiotechnol"},{"issue":"11","key":"4932_CR49","doi-asserted-by":"publisher","first-page":"e165373","DOI":"10.1172\/jci.insight.165373","volume":"8","author":"SS Yandamuri","year":"2023","unstructured":"Yandamuri SS, Filipek B, Obaid AH, Lele N, Thurman JM, Makhani N et al (2023) MOGAD patient autoantibodies induce complement, phagocytosis, and cellular cytotoxicity. JCI insight 8(11):e165373","journal-title":"JCI insight"},{"issue":"3","key":"4932_CR50","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1002\/jcp.29147","volume":"235","author":"L Cheng","year":"2020","unstructured":"Cheng L, Wang C, Yao F, Li Z, Liu W, Jing J (2020) MicroRNA-26b inhibits oligodendrocyte precursor cell differentiation by targeting adrenomedullin in spinal cord injury. J Cell Physiol 235(3):2429\u20132440","journal-title":"J Cell Physiol"},{"issue":"2","key":"4932_CR51","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1111\/1756-185X.14240","volume":"25","author":"S Teng","year":"2022","unstructured":"Teng S, Tian Y, Luo N, Zheng Q, Shao M, Li L (2022) Efficacy and safety of an anti-CD20 monoclonal antibody, rituximab, for lupus nephritis: a meta-analysis. Int J Rheum Dis 25(2):101\u2013109","journal-title":"Int J Rheum Dis"},{"issue":"1","key":"4932_CR52","doi-asserted-by":"publisher","first-page":"32541","DOI":"10.1038\/srep32541","volume":"6","author":"M Mutlu","year":"2016","unstructured":"Mutlu M, Saatci \u00d6, Ansari SA, Yurdusev E, Shehwana H, Konu \u00d6 et al (2016) miR-564 acts as a dual inhibitor of PI3K and MAPK signaling networks and inhibits proliferation and invasion in breast cancer. Sci Rep 6(1):32541","journal-title":"Sci Rep"},{"key":"4932_CR53","doi-asserted-by":"crossref","unstructured":"Venigalla RKC, Turner M (2012) RNA-binding proteins as a point of convergence of the PI3K and p38 MAPK pathways. Frontiers in Immunology 3.","DOI":"10.3389\/fimmu.2012.00398"},{"issue":"8","key":"4932_CR54","doi-asserted-by":"publisher","first-page":"5088","DOI":"10.4049\/jimmunol.0801613","volume":"182","author":"G Alsaleh","year":"2009","unstructured":"Alsaleh G, Suffert G, Semaan N, Juncker T, Frenzel L, Gottenberg J-E et al (2009) Bruton\u2019s tyrosine kinase is involved in miR-346-related regulation of IL-18 release by lipopolysaccharide-activated rheumatoid fibroblast-like synoviocytes. J Immunol 182(8):5088\u20135097","journal-title":"J Immunol"},{"key":"4932_CR55","doi-asserted-by":"crossref","unstructured":"Ihim SA, Abubakar SD, Zian Z, Sasaki T, Saffarioun M, Maleknia S, et al (2022) Interleukin-18 cytokine in immunity, inflammation, and autoimmunity: biological role in induction, regulation, and treatment. Frontiers in Immunology 13.","DOI":"10.3389\/fimmu.2022.919973"},{"issue":"3","key":"4932_CR56","doi-asserted-by":"publisher","first-page":"4857","DOI":"10.1080\/21655979.2022.2036400","volume":"13","author":"L-Y Zhao","year":"2022","unstructured":"Zhao L-Y, Xin G-J, Tang Y-Y, Li X-F, Li Y-Z, Tang N et al (2022) miR-664b-3p inhibits colon cell carcinoma via negatively regulating budding uninhibited by benzimidazole 3. Bioengineered 13(3):4857\u20134868","journal-title":"Bioengineered"},{"issue":"23","key":"4932_CR57","doi-asserted-by":"publisher","first-page":"777","DOI":"10.21037\/atm.2019.11.29","volume":"7","author":"Z Pan","year":"2019","unstructured":"Pan Z, Gan W, Liang C, Xiao Y, Zhang Y, Yang W et al (2019) miR-1245a promotes the proliferation and invasion of colon adenocarcinoma by targeting BRCA2. Annals of Translational Medicine 7(23):777","journal-title":"Annals of Translational Medicine"},{"key":"4932_CR58","doi-asserted-by":"crossref","unstructured":"Wang H, Chen X, Yang B, Xia Z, Chen Q (2020) MiR-924 as a tumor suppressor inhibits non-small cell lung cancer by inhibiting RHBDD1\/Wnt\/\u03b2-catenin signaling pathway. Cancer Cell International 20(1).","DOI":"10.1186\/s12935-020-01516-0"},{"issue":"11","key":"4932_CR59","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.3390\/cells8111380","volume":"8","author":"M Haseeb","year":"2019","unstructured":"Haseeb M, Pirzada RH, Ain QU, Choi S (2019) Wnt signaling in the regulation of immune cell and cancer therapeutics. Cells 8(11):1380","journal-title":"Cells"},{"issue":"4","key":"4932_CR60","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1007\/s10571-017-0550-9","volume":"38","author":"A Vall\u00e9e","year":"2018","unstructured":"Vall\u00e9e A, Vall\u00e9e J-N, Guillevin R, Lecarpentier Y (2018) Interactions between the canonical WNT\/beta-catenin pathway and PPAR gamma on neuroinflammation, demyelination, and remyelination in multiple sclerosis. Cell Mol Neurobiol 38(4):783\u2013795","journal-title":"Cell Mol Neurobiol"},{"issue":"5","key":"4932_CR61","doi-asserted-by":"publisher","first-page":"6219","DOI":"10.1007\/s11033-011-1441-7","volume":"39","author":"SR Siegel","year":"2012","unstructured":"Siegel SR, Mackenzie J, Chaplin G, Jablonski NG, Griffiths L (2012) Circulating microRNAs involved in multiple sclerosis. Mol Biol Rep 39(5):6219\u20136225","journal-title":"Mol Biol Rep"},{"issue":"2","key":"4932_CR62","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1083\/jcb.200110138","volume":"157","author":"M Simons","year":"2002","unstructured":"Simons M, Kramer EM, Macchi P, Rathke-Hartlieb S, Trotter J, Nave KA et al (2002) Overexpression of the myelin proteolipid protein leads to accumulation of cholesterol and proteolipid protein in endosomes\/lysosomes: implications for Pelizaeus-Merzbacher disease. J Cell Biol 157(2):327\u2013336","journal-title":"J Cell Biol"},{"key":"4932_CR63","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.gene.2018.07.062","volume":"678","author":"G CakmakGenc","year":"2018","unstructured":"CakmakGenc G, Dursun A, Karakas Celik S, Calik M, Kokturk F, Piskin IE (2018) IL28B, IL29 and micro-RNA 548 in subacute sclerosing panencephalitis as a rare disease. Gene 678:73\u201378","journal-title":"Gene"},{"issue":"1","key":"4932_CR64","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1755-8794-7-26","volume":"7","author":"B De Felice","year":"2014","unstructured":"De Felice B, Mondola P, Sasso A, Orefice G, Bresciamorra V, Vacca G et al (2014) Small non-coding RNA signature in multiple sclerosis patients after treatment with interferon-\u03b2. BMC Med Genomics 7(1):26","journal-title":"BMC Med Genomics"},{"issue":"2","key":"4932_CR65","doi-asserted-by":"publisher","first-page":"e12162","DOI":"10.1002\/jev2.12162","volume":"11","author":"S Gelibter","year":"2022","unstructured":"Gelibter S, Marostica G, Mandelli A, Siciliani S, Podini P, Finardi A et al (2022) The impact of storage on extracellular vesicles: a systematic study. J Extracell Vesicles 11(2):e12162","journal-title":"J Extracell Vesicles"},{"issue":"1","key":"4932_CR66","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1186\/s12974-024-03148-x","volume":"21","author":"A D'Ambrosio","year":"2024","unstructured":"D\u2019Ambrosio A, Zamboni S, Camerini S, Casella M, Sanchez M, Pietraforte D et al (2024) Proteomic profile of extracellular vesicles from plasma and CSF of multiple sclerosis patients reveals disease activity-associated EAAT2. J Neuroinflammation 21(1):217","journal-title":"J Neuroinflammation"},{"issue":"8","key":"4932_CR67","doi-asserted-by":"publisher","first-page":"e12358","DOI":"10.1002\/jev2.12358","volume":"12","author":"Z Zhang","year":"2023","unstructured":"Zhang Z, Yu K, You Y, Jiang P, Wu Z, DeTure MA et al (2023) Comprehensive characterization of human brain-derived extracellular vesicles using multiple isolation methods: Implications for diagnostic and therapeutic applications. J Extracell Vesicles 12(8):e12358","journal-title":"J Extracell Vesicles"},{"issue":"1","key":"4932_CR68","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s40824-023-00353-2","volume":"27","author":"YO Jang","year":"2023","unstructured":"Jang YO, Ahn HS, Dao TNT, Hong J, Shin W, Lim YM et al (2023) Magnetic transferrin nanoparticles (MTNs) assay as a novel isolation approach for exosomal biomarkers in neurological diseases. Biomater Res 27(1):12","journal-title":"Biomater Res"},{"issue":"6","key":"4932_CR69","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/s41592-021-01174-8","volume":"18","author":"M Norman","year":"2021","unstructured":"Norman M, Ter-Ovanesyan D, Trieu W, Lazarovits R, Kowal EJ, Lee JH et al (2021) L1CAM is not associated with extracellular vesicles in human cerebrospinal fluid or plasma. Nat Methods 18(6):631\u2013634","journal-title":"Nat Methods"},{"key":"4932_CR70","doi-asserted-by":"crossref","unstructured":"Kadam V, Wacker M, Oeckl P, Korneck M, Dannenmann B, Skokowa J, et al (2024) Most L1CAM is not associated with extracellular vesicles in human biofluids and iPSC\u2013derived neurons. bioRxiv 2024.10. 14.618132.","DOI":"10.1101\/2024.10.14.618132"},{"key":"4932_CR71","doi-asserted-by":"crossref","unstructured":"Manna I, De Benedittis S, Porro D (2024) Extracellular vesicles in multiple sclerosis: their significance in the development and possible applications as therapeutic agents and biomarkers. Genes (Basel) 15(6).","DOI":"10.3390\/genes15060772"},{"key":"4932_CR72","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jaut.2019.04.002","volume":"101","author":"E Piket","year":"2019","unstructured":"Piket E, Zheleznyakova GY, Kular L, Jagodic M (2019) Small non-coding RNAs as important players, biomarkers and therapeutic targets in multiple sclerosis: a comprehensive overview. J Autoimmun 101:17\u201325","journal-title":"J Autoimmun"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-04932-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-025-04932-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-04932-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T15:45:58Z","timestamp":1757173558000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-025-04932-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,19]]},"references-count":72,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["4932"],"URL":"https:\/\/doi.org\/10.1007\/s12035-025-04932-3","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,19]]},"assertion":[{"value":"6 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised to adjust the order of affiliations and the assignment of those affiliations to each author.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"A signed informed consent was received from all the participants. This study has been approved from the institutional review board of the Samsung Medical Center (IRB No. 2020\u201304 -\u2009119).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval and Consent to Participate"}},{"value":"Signed informed consent was received from all the participants including consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"JHM is funded by and has received research support from the National Research Foundation of Korea (MIST and KHIDI) and SMC Research and Development grant. She has lectured, consulted, and received honoraria from Bayer Healthcare, Merk, Biogen Idec, Sanofi, UCB, Samsung Bioepis, Mitsubishi Tanabe, Celltrion, Roche, Janssen, and AstraZeneca. All other authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}